InverseOne

Find stocks poised to rise, first, with the data

No.183 · Jul 14, 2026 (Tue)

Today

Samsung Biologics

207940 · KOSPI · Healthcare

₩112,507-1.8%

Why a candidate

Exp 36/100
Upside +35%

Market data

Volume
5.8M
Market cap
₩1,433,272.5T
52-week range
₩91,131 – ₩151,884
P/E
26.0
P/B
1.01
Dividend yield
2.90%
52-week position35/100
₩91,131₩151,884
Upside to 52w high+35.0%

Fund-flow signal

Unlock this stock's fund-flow signal and multi-day trend

Name · deep signal · 7-day trend · trade

Same-sector stocks

These figures are reference estimates built from price and volume: a starting point for narrowing down ideas, not a buy or sell signal.

Today's read

Samsung Biologics scores 36 out of 100 on today's InverseOne expectation ranking, 18 of 30 in the Korean large-cap universe. There is 35% of room left to its 52-week high. Today's move of -1.8% came with money flowing out; the broader Healthcare sector flow is worth checking. Scores are estimates built from price and volume, a starting point for research rather than a trading signal.

Data basis: 2026-07-14 · For reference only · not advice

Same-sector stocks · Healthcare